The methods used for sacrifice of animals and the time taken for any dissection procedures of the brain tissue at room temperature have been shown to influence the number of available binding sites for [3H] leucine enkephalin (10 nM) to mouse brain homogenates. These factors should be considered when utilizing receptor binding techniques as an indirect method for evaluating the in vitro functional state of opiate receptor populations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0091-3057(81)90041-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Collision cross sections of large positive fullerene molecular ions and their use as ion mobility calibrants in trapped ion mobility mass spectrometry.
Anal Bioanal Chem
November 2024
Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany.
Positive-ion laser desorption/ionization (LDI) of fullerenes contained in soot as produced by the Krätschmer-Huffman process delivers a wide range of fullerene molecular ions from C to above C. Here, the collision cross section (CCS) values of those fullerene molecular ions are determined using a trapped ion mobility-quadrupole-time-of-flight (TIMS-Q-TOF) instrument. While CCS values in the range from C to C are already known with high accuracy, those of ions from C onward had yet to be determined.
View Article and Find Full Text PDFInflammatory pain resolution by mouse serum-derived small extracellular vesicles.
Brain Behav Immun
January 2025
Department of Pharmacology & Physiology, Drexel University College of Medicine, 245 North 15th Street, Mail Stop 488, Room 8223, Philadelphia, PA 19102, USA. Electronic address:
Current treatments for chronic pain have limited efficacy and significant side effects, warranting research on alternative strategies for pain management. One approach involves using small extracellular vesicles (sEVs), or exosomes, to transport beneficial biomolecular cargo to aid pain resolution. Exosomes are 30-150 nm sEVs that can be beneficial or harmful depending on their source and cargo composition.
View Article and Find Full Text PDFEffects of Neonatal Administration of Non-Opiate Analogues of Leu-Enkephalin on the Delayed Cardiac Consequences of Intrauterine Hypoxia.
Bull Exp Biol Med
September 2024
Far-East State Medical University, Ministry of Health of the Russian Federation, Khabarovsk, Russia.
Intrauterine hypoxia (gestation days 15-19, pO 65 mm Hg, duration 4 h) led to an increase in the expression of p53, beclin-1, endothelial NO synthase (eNOS), and caspase-3 proteins in cardiomyocytes and reduced the number of mast cells in the heart of 60-day-old albino rats. Administration of a non-opiate analogue of leu-enkephalin (NALE peptide: Phe-D-Ala-Gly-Phe-Leu-Arg, 100 μg/kg) on days 2-6 of the neonatal period decreased the severity of delayed posthypoxic myocardial reaction. The content of eNOS cardiomyocytes and the total number of mast cells of these animals did not differ from the control parameters; the content of p53 cardiomyocytes was significantly lower than in animals exposed to intrauterine hypoxia.
View Article and Find Full Text PDFGegen Qinlian decoction alleviates depression-like behavior by modulating the gut microenvironment in CUMS rats.
BMC Complement Med Ther
September 2024
Department of Human Anatomy and Histoembryology, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Background: Gegen Qinlian Decoction (GQD) is a classical traditional Chinese medicine (TCM) formula primarily utilized for treating gut disorders. GQD showed therapeutic effects on several diseases in clinical and animal studies by targeting gut microbes. Our recent studies also found that GQD efficiently alleviated anxiety in methamphetamine-withdrawn mice via regulating gut microbiome and metabolism.
View Article and Find Full Text PDFKetamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors.
Mol Pharmacol
October 2024
Departments of Pharmacological Sciences (I.G., A.G., L.A.D.) and Psychiatry (L.A.D.), and Nash Family Department of Neuroscience (L.A.D.), Icahn School of Medicine at Mount Sinai, New York, New York; UCSF Weill Institute for Neurosciences, Department of Neurology, Neuroscience Graduate Program, University of California, San Francisco, California (E.B.M.); and Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York (L.D.F.)
Ketamine is a glutamate receptor antagonist that was developed over 50 years ago as an anesthetic agent. At subanesthetic doses, ketamine and some metabolites are analgesics and fast-acting antidepressants, presumably through targets other than glutamate receptors. We tested ketamine and its metabolites for activity as allosteric modulators of opioid receptors expressed as recombinant receptors in heterologous systems and with native receptors in rodent brain; signaling was examined by measuring GTP binding, -arrestin recruitment, MAPK activation, and neurotransmitter release.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!